About Daniel Charytonowicz
Form D filings for Panacent Bio in 2024 list Daniel Charytonowicz as executive officer.
Daniel Charytonowicz first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Charytonowicz in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Charytonowicz works with at each company, as listed on that company's latest Form D.
Panacent Bio Inc. · Form D, Jul 12, 2024
RS
Robert Sebra
CEO and director